MedTrace Logo

Effects of Fish Oil on Post Ablation Arrhythmias

NCT00791089 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2017-09-12

Study results available
· View outcomes & findings →

Summary

To determine if peri-operative treatment with omega-3 fatty acids is associated with a decrease in the incidence of early recurrences of atrial arrhythmias (within 30 days) and an improvement in probability of long-term maintenance of sinus rhythm after radiofrequency catheter ablation for Atrial Fibrillation.

Conditions

Interventions

DRUG

LOVAZA Omega 3-acid ethyl esters

Treatment with omega-3 fatty acids (4g/day) for 4 weeks before and 3 months after radiofrequency catheter ablation for AF.

DRUG

LOVAZA

(EPA+DHA 4 gram/day) for 4 weeks before and 3 months after the ablation procedure.

OTHER

placebo

Control group will receive placebo before \& after ablation.

Sponsors & Collaborators

Principal Investigators

  • Hakan Oral, MD · University of Michigan Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2009-12-31
Completion
2011-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00791089 on ClinicalTrials.gov